Skip to content Skip to footer
Subscribe Now
Spotlight_Barbara Albientz
EVENTS

Reuters Pharma 2025: Post-Conference Talks Featuring Barbara Albientz

Barbara Albientz, Chief Commercialization Officer, Helvion Pharmaceuticals, joins PharmaShots’ Managing Editor Himanshu Sehgal for a riveting dialogue exchange. Barbara shares her experience from the recently held Reuters Events Pharma 2025, where she joined as an affirmative team member for the debate Reality Check: Is Omnichannel Actually Working? Barbara believes AI will be crucial in segmenting…
May 1, 2025

Read more

Spotlight_Jayasree Iyer
EVENTS

Reuters Pharma 2025: Post Conference Talks Featuring Jayasree K. Iyer 

Jayasree K. Iyer, CEO of Access to Medicine Foundation, moderated a panel discussion that featured leaders from the 2024 Access to Medicine Index. Jayasree highlighted how biopharma companies foster accessibility to essential medicines in low- and middle-income countries through global partnerships, innovation, and sustainable models. Jayasree talks about the future of Health Equity amidst the…
April 29, 2025

Read more

Viewpoints_Jesse Mendelsohn
VIEWPOINTS

Predicting 2025 Trends: Jesse Mendelsohn from Model N in an Illuminating Discussion with PharmaShots

Shots:  Several undulating factors coalesce to inadvertently shape the biopharma industry  Prominent challenges include mounting pressure on Pharmacy Benefit Managers from independent pharmacies and drug manufacturers, a growing shortage of GLP-1 drugs, and the addition of 15 more drugs to the Inflation Reduction Act’s price negotiation list.  Jesse Mendelsohn, SVP at Model N, emphasizes the…
April 28, 2025

Read more

Thoughtspot_Saurabh_Chaubey
THOUGHTSPOT

Personalized Medicine: A Paradigm Shift in Modern Treatment Approach

Shots:   Precision medicine holds a promising foothold in addressing unmet healthcare needs and bridging the gaps in care accessibility and high treatment costs  Defying the one-size-fits-all model, personalized medicine offers therapies tailored to an individual’s physiology, lifestyle, and environment  With this article, let’s capture the intricacies of precision medicine by navigating the benefits, challenges, progress,…
April 23, 2025

Read more

Spotlight Interview_Hector De La Riva
EVENTS

Reuters Pharma 2025: Post-Conference Talks Featuring Hector De La Riva

Hector De La Riva joins PharmaShots Managing Editor Himanshu Sehgal for a riveting conversation on his recent panel discussion at Reuters Events Pharma 2025. “Reimagine Your 2025 Sales Strategy,” the topic of his panel discussion, examined the ever-evolving commercial landscape and the role of field engagement and customer empowerment in shaping strategic investments. Hector stresses…
April 22, 2025

Read more

Viewpoints_Vijay Nadipelli
VIEWPOINTS

Evaluating SDoH in SLE: Vijay Nadipelli from GSK in a Riveting Conversation with PharmaShots

Shots:  SDoH screening can help identify patient needs, support faster clinical decisions, and improve patient-centric care  A first-of-its-kind lupus study surveyed 69 patients across two institutions to assess the feasibility of routine SDoH screening in lupus clinics and identify related barriers and enablers at the physician, care team, and patient levels  Vijay Nadipelli, Senior Director…
April 21, 2025

Read more

Viewpoints_Kate Flathers
VIEWPOINTS

Streamlining Pharmaceutical Claims: Kate Flathers from Kalderos in a Stimulating Conversation with PharmaShots

Shots:   Streamlining claims transactions remains a major challenge for pharmaceutical manufacturers. The financial leakage owing to non-compliant and duplicate claims costs manufacturers a fortune   Using Kalderos' Truzo platform, manufacturers can pay covered entities directly while maintaining transparency and compliance  Kate Flathers, Chief Product Officer at Kalderos, addresses the need for a compliant model for claims…
April 17, 2025

Read more

Announcements

PharmaShots Announces Strategic Data Partnership with AlphaSense 

PharmaShots is pleased to announce a new strategic data partnership with AlphaSense, marking an important milestone in our mission to elevate the quality, accessibility, and impact of insights across the biopharma and healthcare ecosystem.  This collaboration strengthens our commitment to reimagining intelligence and delivering unmatched industry updates that empower researchers, students, analysts, and biopharma professionals worldwide. By…
April 13, 2025

Read more

Load more